Accordingly, the liver might promote steatosis by enhancing HIF-1α and inhibiting SIRT1 signaling that stimulates hepatosteatosis in ob/ob mice, and these phenomena were neutralized by losartan. This evidence concerns the gene HIF1A and steatosis.